Daily oral emtricitabine/tenofovir preexposure prophylaxis and herpes simplex virus type 2 among men who have sex with men.

Daily oral emtricitabine/tenofovir preexposure prophylaxis and herpes simplex virus type 2 among men who have sex with men.

In addition to protecting against HIV acquisition, antiretroviral preexposure prophylaxis (PrEP) using topical 1% tenofovir gel reduced Herpes simplex virus type 2 (HSV-2) acquisition by 51% among women in the CAPRISA 004 study. We examined the effect of daily oral emtricitabine/tenofovir (FTC/TDF)...

Full description

Bibliographic Details
Main Authors: Julia L Marcus, David V Glidden, Vanessa McMahan, Javier R Lama, Kenneth H Mayer, Albert Y Liu, Orlando Montoya-Herrera, Martin Casapia, Brenda Hoagland, Robert M Grant
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3956614?pdf=render

Internet

http://europepmc.org/articles/PMC3956614?pdf=render

Similar Items